![Optimization of Physicochemical Properties of Pyrrolidine GPR40 AgoPAMs Results in a Differentiated Profile with Improved Pharmacokinetics and Reduced Off-Target Activities - ScienceDirect Optimization of Physicochemical Properties of Pyrrolidine GPR40 AgoPAMs Results in a Differentiated Profile with Improved Pharmacokinetics and Reduced Off-Target Activities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0968089623001219-ga1.jpg)
Optimization of Physicochemical Properties of Pyrrolidine GPR40 AgoPAMs Results in a Differentiated Profile with Improved Pharmacokinetics and Reduced Off-Target Activities - ScienceDirect
![Frontiers | Delayed Rebound of Glycemia During Recovery Following Short-Duration High-Intensity Exercise: Are There Lactate and Glucose Metabolism Interactions? Frontiers | Delayed Rebound of Glycemia During Recovery Following Short-Duration High-Intensity Exercise: Are There Lactate and Glucose Metabolism Interactions?](https://www.frontiersin.org/files/Articles/734152/fnut-08-734152-HTML-r1/image_m/fnut-08-734152-g001.jpg)
Frontiers | Delayed Rebound of Glycemia During Recovery Following Short-Duration High-Intensity Exercise: Are There Lactate and Glucose Metabolism Interactions?
![IJMS | Free Full-Text | New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions IJMS | Free Full-Text | New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions](https://www.mdpi.com/ijms/ijms-22-10643/article_deploy/html/images/ijms-22-10643-g001.png)
IJMS | Free Full-Text | New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
![Contribution of the Dawn Phenomenon to the Fasting and Postbreakfast Hyperglycemia In Type 1 Diabetes Treated With Once-Nightly Insulin Glargine - Endocrine Practice Contribution of the Dawn Phenomenon to the Fasting and Postbreakfast Hyperglycemia In Type 1 Diabetes Treated With Once-Nightly Insulin Glargine - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/d765801e-f3f3-4eb1-ae0e-1f56835e025c/gr1.jpg)
Contribution of the Dawn Phenomenon to the Fasting and Postbreakfast Hyperglycemia In Type 1 Diabetes Treated With Once-Nightly Insulin Glargine - Endocrine Practice
![Glucose Counterregulation and Waning of Insulin in the Somogyi Phenomenon (Posthypoglycemic Hyperglycemia) | NEJM Glucose Counterregulation and Waning of Insulin in the Somogyi Phenomenon (Posthypoglycemic Hyperglycemia) | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1984/nejm_1984.311.issue-19/nejm198411083111904/20130822/images/img_small/nejm198411083111904_f1.jpeg)